

Overview
Albuminuria serves as a vital early marker of cardiovascular and kidney disease in diabetic patients,
reflecting underlying vascular damage and increased health risks.
This module covers the
significance of albuminuria in risk assessment and the protective role of Irbesartan in managing its
progression, with a focus on kidney preservation. Participants will also learn to implement antihypertensive
therapies that offer cardiovascular protection, gaining practical strategies to enhance patient outcomes in
cardio-renal health.
Hypertension
Chronic Kidney Disease
Albuminuria Management
RAAS Inhibitors Treatment guidelines
Speaker
Elmer Jasper B. Llanes, MD, FPCP, FPCC
Nuclear Cardiologist
Vice President, Philippine Lipid and Atherosclerosis Society
Past Chair, Council of Preventive Cardiology, Philippine Heart Association
Clinical Associate Professor, University of the Philippines - Philippine General Hospital